Arkolith/Insider Trading/TNYA/Form 4

Ali Faraz

Chief Executive Officer, DirectorTenaya Therapeutics, Inc. (TNYA) · full profile →Form 4 · filed Feb 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2026Sell(S)5K$0.64$3K443K
Feb 17, 2026Sell(S)6K$0.64$4K452K
Feb 17, 2026Sell(S)4K$0.64$3K448K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-055442) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML